Menopause Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Hormonal Treatment and Non-Hormonal Treatment), By Application (Hospitals, Clinic and Others) and Regional Insights and Forecast to 2031

Updated On: 29 April 2024

MENOPAUSE TREATMENT MARKET REPORT OVERVIEW

• 

• to learn more about this report

The global menopause treatment market size was USD 2521.7 million in 2019 and will touch USD 2978.9 million in 2026, exhibiting a CAGR of 2.4% during the forecast period.

Menopause, commonly known as the climacteric, marks a significant life stage for most women, signifying the permanent cessation of menstrual periods and the end of fertility, typically occurring between 49 and 52 years of age. Healthcare professionals often identify menopause as the absence of vaginal bleeding for a continuous year or a decline in ovarian hormone production. In cases where women undergo a hysterectomy but retain their ovaries, menopause may be considered to have occurred at the time of surgery or when hormone levels decrease, with symptoms emerging at an earlier average age of 45.

Menopause, a natural life stage, doesn't inherently necessitate medical intervention. However, when perimenopausal impacts disrupt a woman's life significantly, palliative medical therapy may be considered. Treatment often involves hormone replacement therapy (HRT) with estrogen, progesterone, and sometimes testosterone to alleviate symptoms such as hot flashes and mood swings. Alternative approaches encompass SSRIs, lifestyle changes, and non-hormonal medications. Practices such as yoga, acupuncture, and vaginal lubricants contribute to effective management. Consulting a healthcare provider is crucial for a personalized treatment plan based on individual needs and medical history.

COVID-19 Impact: Pandemic has reshaped menopause service delivery with telehealth services embraced in the market

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The pandemic has significantly transformed menopause treatment, driven by the adoption of telehealth. This paradigm shift is well-received among women seeking care for menopause-related issues. Widespread acceptance of telehealth implies a potential impact on the demand for the menopause treatment market, as more women express willingness to seek assistance through virtual platforms. The move towards remote consultations aligns with broader trends in healthcare delivery, promising enhanced accessibility and patient engagement in menopause treatment services.

LATEST TRENDS

"Home menopause hormone analysis kits are expected to drive the market"

An introduced home-based menopause hormone analysis kit offers immediate insights into a user's menopausal status, duration, and cycle. This innovative solution empowers individuals to monitor and comprehend their menopausal journey from the comfort of their homes. Utilizing sophisticated hormone analysis technology, it facilitates real-time assessment, providing comprehensive information about the user's current menopausal stage. The kit's capacity to deliver insights into the duration and cycle of menopause enhances its utility for women navigating this life stage. This home-based approach represents a convenient and accessible means for individuals to obtain valuable information about their hormonal health, contributing to a proactive and informed approach to managing various facets of menopause. The kit stands as a testament to the evolving healthcare landscape, where personalized and home-based solutions play a pivotal role in promoting women's well-being during menopause.

MENOPAUSE TREATMENT MARKET SEGMENTATION

• 

• to learn more about this report

• By Type

Based on type the global market can be categorized into Hormonal Treatment and Non-Hormonal Treatment.

Hormonal Treatment: Hormonal menopause treatment, utilizing estrogen, progesterone, or a combination, alleviates symptoms such as hot flashes and mood swings. Administered via pills, patches, gels, or injections, it tackles the decline in hormone levels. Specific medications, such as estrogen therapy, present diverse administration routes. While offering relief from vasomotor symptoms and preventing bone loss, hormonal treatment involves certain risks. The market is influenced by evolving lifestyles, increasing awareness, and research investments.

Non-Hormonal Treatment: Non-hormonal menopause treatment includes anti-depressants, anti-anxiety medications, and anti-migraine drugs for managing symptoms such as mood changes and hot flashes. It also encompasses non-hormonal therapies such as herbal supplements, cognitive-behavioural therapy, and lifestyle modifications. Specific medications, such as paroxetine, an approved anti-depressant, target hot flashes. The market is driven by the demand for alternative therapies, the popularity of natural options, and the increasing prevalence of menopausal symptoms. Non-hormonal treatments present significant opportunities, especially in regions with cultural taboos and limited healthcare access.

• By Application

Based on application the global market can be categorized into Hospitals, Clinic and Others.

Hospitals: Hospitals, a critical segment in the menopause treatment market, provide specialized care for women with menopausal symptoms. Offering a range of hormonal and non-hormonal therapies, these facilities play a pivotal role in diagnosis, management, and treatment. Increased demand is fueled by rising menopausal symptoms, growing women's health awareness, and advanced healthcare centres. In developed regions, hospitals are expected to maintain significance in the menopause treatment market.

Clinics: Clinics, especially gynaecology and menopause-focused, are vital for tailored menopause treatment. Providing diverse services such as hormonal/non-hormonal treatments, counselling, and support, clinics contribute to early detection and personalized management. Demand is propelled by growing awareness, acceptance of menopause, specialized healthcare accessibility, and a rising focus on preventive healthcare. Clinics are expected to persist as a significant segment of the menopause treatment market, particularly in urban and suburban areas.

Others: The "Others" category in menopause treatment embraces diverse settings such as homecare, telehealth, and community health centres, evolving the care landscape. Offering alternative options, including remote consultations, self-care products, and community support, it highlights patient-centred, accessible healthcare beyond traditional settings. Demand is driven by increasing telehealth adoption, innovative products, and a preference for personalized healthcare. The "Others" segment is poised to gain prominence in the menopause treatment market, catering to evolving women's health needs.

DRIVING FACTORS

"Growing changes in lifestyles and dietary habits among women are boosting the market"

The growing adoption of lifestyle and dietary changes among women is driving the global menopause treatment market growth. Rising rates of smoking, alcohol consumption, and decreased physical activity are prevalent trends observed in women worldwide. These factors can accelerate the onset and intensity of menopausal symptoms, increasing the demand for related products and services. According to World Health Organization (WHO) data, a small percentage of females engage in tobacco consumption, a significant contributor to menopause-related health issues. Conversely, a sedentary lifestyle, common among many women, leads to weight gain and exacerbates menopausal symptoms. These multifaceted factors are instrumental in propelling the upward trajectory of the menopause market.

"Increasing awareness propels the market for solutions and education among women"

The growing awareness and educational initiatives targeting women on menopause-related issues and available solutions are poised to bolster the growth of the menopause market. The continuous influx of advancements in medical research, aimed at innovating diverse treatments and products for menopause, is anticipated to further accelerate the market's expansion. Notably, key market players have actively engaged in research and development activities, introducing various non-hormonal drugs to effectively address symptoms such as hot flashes. This dynamic landscape, characterized by the introduction of a multitude of menopause products and services, is expected to drive heightened demand throughout the forecast period. Moreover, factors such as the escalating role of technology in research and development, increased healthcare expenditure, a rise in over-the-counter product availability, growing disposable income, and a rising population grappling with chronic diseases collectively contribute to propelling the growth trajectory of the menopause market.

RESTRAINING FACTORS

"Numerous side effects of specific menopause symptom treatment procedures hinder the market"

The market grapples with limitations attributed to adverse effects associated with specific menopause symptom treatments, particularly hormone replacement therapy (HRT). Despite its objective to alleviate vasomotor symptoms, HRT comes with complications, including vaginal bleeding, blood clots, stroke, and an elevated risk of breast cancer. These side effects present substantial challenges and raise concerns regarding the widespread adoption of HRT for managing menopausal symptoms. Addressing these drawbacks is crucial for the market's progress, highlighting the necessity for alternative interventions that prioritize both safety and efficacy. Overcoming these challenges emphasizes the importance of developing and implementing solutions that prioritize women's health during the menopausal transition while minimizing associated risks. The market's trajectory hinges on navigating these complexities to ensure the well-being of women seeking effective menopause management.

MENOPAUSE TREATMENT MARKET REGIONAL INSIGHTS

• 

• to learn more about this report

"North America leads the market due to its high prevalence of menopause emphasizing market prominence"

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

The dominance of North America in the global menopause treatment market share is attributed to the region's elevated prevalence of menopause and its associated symptoms. Additionally, the well-established healthcare infrastructure enhances accessibility to menopause treatments for women in the region. The high incidence of menopause-related concerns underscores the significance of the market in North America, where a substantial portion of the female population experiences this life stage. The advanced healthcare system ensures that women have ready access to diverse treatment options, contributing to the market's prominence. The prevalence of menopausal symptoms and the efficient healthcare infrastructure collectively position North America as a key player in the Menopause Treatment market, fostering growth and advancements in addressing the healthcare needs of women during the menopausal transition.

KEY INDUSTRY PLAYERS

"Key industry leaders in the market form partnerships strategically to meet demand and expand client"

Key industry players in advancing the menopause treatment market are engaging in strategic partnerships and collaborations to align with consumer demand and broaden their client base. These industry leaders are directing efforts toward creating cutting-edge menopause treatment products, incorporating innovative technologies in drug development and delivery. The primary focus is on minimizing side effects and enhancing efficacy. Key players in the menopause sector are proactively pursuing collaborative ventures to meet evolving consumer needs, fostering growth and market expansion. Additionally, their commitment to innovation is reflected in the development of disruptive technologies aimed at improving the overall landscape of menopause treatment. The concerted efforts of these influential companies underscore their dedication to addressing women's health during the menopausal transition and driving advancements in treatment modalities.

List of Market Players Profiled

• Merck (U.S.)
• Pfizer (U.S.)
• Eli Lilly And Company (U.S.)
• Emcure Pharmaceuticals (India)
• Cipla (India)
• Novartis (Switzerland)
• Novo Nordisk (Denmark)
• Allergan (Ireland)
• Teva Pharmaceutical Industries (Israel)

INDUSTRIAL DEVELOPMENT

January 2023: Bayer, a German pharmaceutical company, announces positive Phase III results for elinzanetant, a non-hormonal menopausal relief drug targeting hot flashes. This is crucial for Bayer's pharmaceutical division, facing past challenges. Elinzanetant significantly reduces hot flash frequency, enhancing sleep and overall quality of life. It positions Bayer competitively in the non-hormonal menopausal treatment market, amid the recent entry by Astellas Pharma's Veoza. Successful trials indicate elinzanetant as a promising alternative for managing menopausal symptoms. Bayer intends to present detailed trial information at upcoming medical conferences and seeks regulatory approval.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.